# Pediatric HIV Infection: Drug Development for Treatment - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/pediatric-hiv-infection-drug-development-for-treatment/2fd110e1-e45d-44ba-8efb-87a9ba7b8d23

> FDA guidance document: Pediatric HIV Infection: Drug Development for Treatment. Issue date: March 20, 2019. Get complete insights and analysis.

---

## Details

- Title: Pediatric HIV Infection: Drug Development for Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2019-03-20
- Last Changed: 2024-04-11
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-1638">FDA-2018-D-1638</a>

## Related Documents

- [Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/atopic-dermatitis-timing-of-pediatric-studies-during-development-of-systemic-drugs/287c413c-cc5e-49ee-af83-9d7183bc4f4d)
- [Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/amyotrophic-lateral-sclerosis-developing-drugs-for-treatment-guidance-for-industry-guidance-for-industry/933cd61f-72c5-470a-b6e9-21c7a3253529)
- [Bacterial Vaginosis: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/bacterial-vaginosis-developing-drugs-for-treatment-guidance-for-industry/d280b63f-a1bf-46b4-aa9d-41f650dd1b70)